Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Silibinin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 2/3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 31553 | ||||
| Docking Score | -10.082 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H22O10 | ||||
| Molecular Weight | 482.4 | ||||
| Canonical SMILES |
COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O
|
||||
| InChI |
InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23+,24-,25-/m1/s1
|
||||
| InChIKey | SEBFKMXJBCUCAI-HKTJVKLFSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Dronedarone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 208898 | ||||
| Docking Score | -10.07 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C31H44N2O5S | ||||
| Molecular Weight | 556.8 | ||||
| Canonical SMILES |
CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
|
||||
| InChI |
InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3
|
||||
| InChIKey | ZQTNQVWKHCQYLQ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 7.2 | Rotatable Bond Count | 18 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Elacridar Drug Info | ||||
| Xenobiotic Type | Discontinued Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 119373 | ||||
| Docking Score | -10.06 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C34H33N3O5 | ||||
| Molecular Weight | 563.6 | ||||
| Canonical SMILES |
COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC
|
||||
| InChI |
InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
|
||||
| InChIKey | OSFCMRGOZNQUSW-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.6 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.